Company Filing History:

23 out of 1,858

Takeda Chemical Industries, Inc.

patents

3 out of 1,179

Takeda Pharmaceutical Company Limited

patents

Years Active: 1997-2009

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7622479 - Bicyclic derivative, its production and use (2009-11-24),

2. 7569570 - Thienopyrimidines, process for preparing the same and use thereof (2009-08-04),

3. 6962919 - Nitrogen-containing heterocyclic compounds, their production and use (2005-11-08),

4. 6514988 - Condensed-ring thiophene derivatives, their production and use (2003-02-04),

5. 6413972 - Nitrogen-containing heterocyclic compounds, their production and use (2002-07-02),

6. 6340686 - Thienopyrimidine compounds, their production and use (2002-01-22),

7. 6329388 - Thienopyridine compounds, their production and use (2001-12-11),

8. 6313301 - Thienopyridine derivatives, their intermediates and production thereof (2001-11-06),

9. 6297379 - Thienopyrimidine compounds, their production and use (2001-10-02),

10. 6297255 - Thienopyridine compounds, their production and use (2001-10-02),

11. 6262267 - Thienopyridine compound (2001-07-17),

12. 6194419 - Nitrogen-containing heterocyclic compounds, their production and use (2001-02-27),

13. 6187788 - Condensed-ring thiophene derivatives, their production and use (2001-02-13),

14. 6180792 - Condensed-ring thiophene derivatives and thienopyrimide derivatives, their production and use (2001-01-30),

15. 6140325 - Thienopyrimidine derivatives, their production and use (2000-10-31),

Title: **Shuichi Furuya: Innovator in Pharmaceutical Chemistry**

Introduction

Shuichi Furuya, based in Tsukuba, Japan, is a notable inventor with an impressive portfolio of 26 patents. His contributions primarily revolve around pharmaceutical compounds that exhibit significant biological activity.

Latest Patents

Among the latest inventions credited to Furuya are two remarkable patents. The first, titled "Bicyclic derivative, its production and use," introduces a heterocyclic compound known for its potent tyrosine kinase-inhibiting activity. The compound is represented by a specific formula involving various substituents and configurations that enhance its pharmaceutical potential.

The second patent, "Thienopyrimidines, process for preparing the same and use thereof," outlines a thienopyrimidine compound designed for its antagonistic action towards gonadotropin-releasing hormone. The patent thoroughly details the chemical structure and potential applications, underscoring Furuya's focus on developing therapeutic agents.

Career Highlights

Furuya has made significant strides in his career, particularly during his tenure at esteemed companies such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His innovative work in these organizations has helped pave the way for advancements in drug development and medicinal chemistry.

Collaborations

Throughout his career, Furuya has collaborated with notable individuals, including Nobuo Choh and Nobuhiro Suzuki. These partnerships have likely enriched his work, fostering a collaborative environment conducive to innovation and research.

Conclusion

Shuichi Furuya represents a prominent figure in the field of pharmaceutical chemistry, with a robust portfolio of patents that reflect his commitment to advancing medical science. His innovative solutions in drug design and development contribute significantly to the ongoing progress in the industry, making him a key player in the realm of biochemistry and pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com